Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients

Arquivos de Neuro-Psiquiatria

Volumn 67, Issue 3 B, 2009, Pages 866-870

  De Castro Costa, Carlos Maurício ^a   Araújo, Abelardo De Queiroz Campos ^b   Câmara, Carlos C ^a   Ferreira, Ayrton S ^a   Santos, Terezinha De Jesus T ^a   De Castro Costa, Samuel Bovy ^a   Alcântara, Raimundo Neudson M ^a   Taylor, Graham P ^c  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 ASSOCIATED MYELOPATHY; MALE; MOTOR DYSFUNCTION; NEUROPATHIC PAIN; NOCICEPTION; PAIN; PHYSICAL DISABILITY; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TROPICAL SPASTIC PARAPARESIS; VERBAL COMMUNICATION;

EID: 71949098685     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2009000500016     Document Type: Article

References (41)

1. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;8452:407-410. (Pubitemid 15231248)
2. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;8488:1031-1032. (Pubitemid 16102987)
3. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner WA (Ed.) Human retrovirology: HTLV. New York: Raven Press, 1990:191-197.
4. De Castro-Costa CM, Araújo AQ, Barreto MM, et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 2006;22:931-935.
5. Slater CMSA, Monteiro SMC, Shublag M, Faria LC, Puccioni-Sohler M. Comparison between the Osame (1990) and Castro et al. (2006) criteria for the diagnosis of HAM/TSP. Braz J Infect Dis 2008;12(Suppl 1):S19.
6. De Castro-Costa CM, do Vale OC, Goubau P, Desmyter J, Carton H. HTLV-1 and tropical spastic paraparesis in Fortaleza (Northeastern Brazil). J Trop Geographic Neurol 1991;1:45-48.
7. De Castro-Costa CM, Carton H, Goubau P, D'Almeida JA. Brazilian studies on tropical spastic paraparesis. A meta-analysis. Arq Neuropsiquiatr 1994;52:585-591.
8. De Castro-Costa CM, Goubau P, Liu HF, et al. HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern Brazil. AIDS Res Hum Retroviruses 1995;11:315-318.
9. Zunt JR, Montano SM, Alarcón JO, Longstreth WT Jr, Price R, Holmes KK. Quantitative assessment of spasticity in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 2005;11:70-73. (Pubitemid 40458374)
10. Tavares IR, Franzoi AC, Araújo AQC. Low back pain following HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Braz J Infect Dis 2008;12(Suppl 1):S5.
11. Ferreira AS, Costa VV, Saraiva RA. The incidence of neuropathic pain in patients with myelopathy associated with HTLV-1. Braz J Infect Dis 2008;12(Suppl 1):S14.
12. Morgan O. Tropical spastic paraparesis: clinical features. In: Blattner WA (Ed.) Human retrovirology: HTLV. New York: Raven Press, 1990:199-204.
13. McMahon SB, Bennett DHL, Bevan S. Inflammatory mediators and modulators of pain. In: McMahon SB, Koltzenburg M (Eds.) Wall and Melzack's Textbook of Pain, 5th Ed. Elsevier-Churchill-Livingston, 2006:49-72.
14. Devor M. Responses of nerves to injury in relation to neuropathic pain. In: McMahon SB, Koltzenburg M (Eds.) Wall and Melzack's Textbook of pain, 5th Ed. Elsevier-Churchill-Livingston, 2006:905-927.
15. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-1635.
16. Myers RR, Wagner R, Sorkin LS. Hyperalgesia actions of cytokines on peripheral nerves. In: Watkins LR, Maier SF (Eds.) Cytokines and pain. Basel: Birkhäven-Verlag, 1999:133-157.
17. Sachs D, Cunha FQ, Poole S, Ferreira SH. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain 2002;96:89-97. (Pubitemid 34272289)
18. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002;82:981-1011.
19. Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. In: Machelska H, Stein C (Eds.) Immune mechanisms of pain and analgesia. Heidelberg: Kluwer Academic/Plenum Publishers, 2003:1-21.
20. Boureau F, Doubrere JF, Luu M. Study of verbal description in neuropathic pain. Pain 1990;42:145-152. (Pubitemid 20258899)
21. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108:248-257. (Pubitemid 38353047)
22. Kurtzke JF. Further notes on disability evaluation in multiple sclerosis, with scale modifications. Neurology 1965;15:654-661.
23. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990;96:103-123. (Pubitemid 20137633)
24. Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992;117:933-946.
25. Smadja D, Cabre P, Bellance R, Vernant JC. Paraplégie associée à l'HTLV-1 en Martinique. Bull Soc Pathol Exo 1993;86:433-438.
26. Araújo A de Q, Ali A, Newell A, Dalgleish AG, Rudge P. HTLV-I infection and neurological disease in Rio de Janeiro. J Neurol Neurosurg Psychiatry 1992;55:153-155.
27. Melo A, Gomes I, Mattos K. Mielopatias por HTLV-1 na cidade de Salvador, Bahia. Arq Neuropsiquiatr 1994;52:320-325.
28. Cartier L, Araya F, Castillo JL, et al. Retrovirus HTLV-1 en Chile: estudio en 140 enfermos neurológicos. Rev Méd Chil 1990;118:622-628.
29. Araújo AQ, Leite AC, Dultra SV, Andrada-Serpa MJ. Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 1995;129:147-151.
30. Castañeda C, Deza L. Paraparesia espástica tropical asociada a HTLV-I: comunicación de un caso. Rev Neuropsiquiatr 1990;53:103-106.
31. th Ed. Elsevier-Churchill-Livingston, 2006:1029-1042.
32. Araújo AP, Fontenelle LM, Pádua PA, Maia Filho HS, Araújo A de Q. Juvenile human T lymphotropic virus type 1-associated myelopathy. Clin Infect Dis 2002;35:201-204. (Pubitemid 34753907)
33. Cartier L, Ramírez E, Galeno H. Forma familiar de la paraparesia espástica tropical: estudio de cuatro familias. Rev Méd Chil 1998;126:419-426.
34. Sheremata WA, Berger JR, Harrington WJ Jr, Ayyar DR, Stafford M, De Freitas E. Human T lymphotropic virus type I-associated myelopathy. A report of 10 patients born in the United States. Arch Neurol 1992;49:1113-1138.
35. Haussen SR, de Vecino MC. HTLV-I associated myelopathy/tropical spastic paraparesis. Report of the first cases in Rio Grande do Sul, Brazil. Arq Neuropsiquiatr 1995;53:608-612.
36. Biglione MM, Pizarro M, Puca A, Salomón HE, Berría MI. A cluster of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina. J Acquir Immune Defic Syndr 2003;32:441-445. (Pubitemid 36367199)
37. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 1992;8:338-345. (Pubitemid 23039034)
38. Santos TJT, De Castro-Costa CM, Giffoni SDA, Santos FJC, Ramos RSN, Gifoni MAC. The effect of baclofen on spontaneous and evoked behavioural expression of experimental neuropathic chronic pain. Arq Neuropsiquiatr 1999;57:753-760.
39. Taylor GP. Pathogenesis and treatment of HTLV-I associated myelopathy. Sex Transm Infect 1998;74:316-322. (Pubitemid 28467319)
40. Furukawa Y, Saito M, Matsumoto W, et al. Different cytokine production in tax-express ing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associ ated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers. J Infect Dis 2003;187:1116-1125. (Pubitemid 36401613)
41. Muniz AL, Rodrigues W Jr, Santos SB, et al. Association of cytokines, neurological disability, and disease duration in HAM/TSP patients. Arq Neuropsiquiatr 2006;64:217-221.